Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol

Background The hepatic endocannabinoid system and cytochrome P450 2E1 (CYP2E1), a key enzyme causing alcohol-induced reactive oxygen species (ROS) generation, are major contributors to the pathogenesis of alcoholic liver disease. The nuclear hormone receptor oestrogen-related receptor γ (ERRγ) is a constitutively active transcriptional activator regulating gene expression. Objective To investigate the role of ERRγ in the alcohol-mediated regulation of CYP2E1 and to examine the possibility to control alcohol-mediated oxidative stress and liver injury through an ERRγ inverse agonist. Design For chronic alcoholic hepatosteatosis study, C57BL/6J wild-type and CB1−/− mice were administered alcohol for 4 weeks. GSK5182 and chlormethiazole (CMZ) were given by oral gavage for the last 2 weeks of alcohol feeding. Gene expression profiles and biochemical assays were performed using the liver or blood of mice. Results Hepatic ERRγ gene expression induced by alcohol-mediated activation of CB1 receptor results in induction of CYP2E1, while liver-specific ablation of ERRγ gene expression blocks alcohol-induced expression of CYP2E1 in mouse liver. An ERRγ inverse agonist significantly ameliorates chronic alcohol-induced liver injury in mice through inhibition of CYP2E1-mediated generation of ROS, while inhibition of CYP2E1 by CMZ abrogates the beneficial effects of the inverse agonist. Finally, chronic alcohol-mediated ERRγ and CYP2E1 gene expression, ROS generation and liver injury in normal mice were nearly abolished in CB1−/− mice. Conclusions ERRγ, as a previously unrecognised transcriptional regulator of hepatic CB1 receptor, controls alcohol-induced oxidative stress and liver injury through CYP2E1 induction, and its inverse agonist could ameliorate oxidative liver injury due to chronic alcohol exposure.

[1]  R. Bataller,et al.  Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. , 2012, Gastroenterology.

[2]  S. Koo,et al.  Orphan Nuclear Receptor Estrogen-Related Receptor γ (ERRγ) Is Key Regulator of Hepatic Gluconeogenesis* , 2012, The Journal of Biological Chemistry.

[3]  R. Bataller,et al.  Alcoholic liver disease: pathogenesis and new therapeutic targets. , 2011, Gastroenterology.

[4]  A. Mallat,et al.  Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice , 2011, Hepatology.

[5]  J. Min,et al.  Estrogen-related Receptor γ (ERRγ) Is a Novel Transcriptional Regulator of Phosphatidic Acid Phosphatase, LIPIN1, and Inhibits Hepatic Insulin Signaling* , 2011, The Journal of Biological Chemistry.

[6]  G. Godlewski,et al.  Endocannabinoids in liver disease , 2011, Hepatology.

[7]  C. Constantinescu,et al.  Cannabinoids and the immune system: an overview. , 2010, Immunobiology.

[8]  M. Pangalos,et al.  Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice , 2010, The Journal of Neuroscience.

[9]  Defeng Wu,et al.  Role of oxidative stress in alcohol-induced liver injury , 2009, Archives of Toxicology.

[10]  L. Hanuš.  Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids , 2009, Medicinal research reviews.

[11]  J. Morrow,et al.  Development of Oxidative Stress by Cytochrome P450 Induction in Rodents Is Selective for Barbiturates and Related to Loss of Pyridine Nucleotide-dependent Protective Systems* , 2008, Journal of Biological Chemistry.

[12]  A. Cederbaum,et al.  Cytochrome P450 2E1 contributes to ethanol‐induced fatty liver in mice , 2008, Hepatology.

[13]  G. Marsicano,et al.  Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. , 2008, Cell metabolism.

[14]  A. Cederbaum,et al.  CYP2E1 and oxidative liver injury by alcohol. , 2008, Free radical biology & medicine.

[15]  F. Guengerich,et al.  Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli. , 2008, Protein expression and purification.

[16]  V. Giguère.  Transcriptional control of energy homeostasis by the estrogen-related receptors. , 2008, Endocrine reviews.

[17]  A. Cederbaum,et al.  CYP 2 E 1 and Oxidative Liver Injury by Alcohol , 2008 .

[18]  J. Morrow,et al.  In Vivo Oxidative Damage in Rats Is Associated with Barbiturate Response but Not Other Cytochrome P450 Inducers , 2007, Molecular Pharmacology.

[19]  R. Schwabe,et al.  The endocannabinoid 2‐arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  P. Pacher,et al.  Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. , 2007, American journal of physiology. Heart and circulatory physiology.

[21]  R. Naviaux,et al.  ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. , 2007, Cell metabolism.

[22]  M. Blanchette,et al.  Genome-wide Orchestration of Cardiac Functions by the Orphan Nuclear Receptors ERRα and γ , 2007 .

[23]  Mathieu Blanchette,et al.  Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. , 2007, Cell metabolism.

[24]  Shiuan Chen,et al.  Molecular cloning and functional study of rat estrogen receptor‐related receptor γ in rat prostatic cells , 2006, The Prostate.

[25]  T. Ahn,et al.  Tissue-specific effect of ascorbic acid supplementation on the expression of cytochrome P450 2E1 and oxidative stress in streptozotocin-induced diabetic rats. , 2006, Toxicology letters.

[26]  Seung-Wook Ryu,et al.  JNK- and p38 Kinase-mediated Phosphorylation of Bax Leads to Its Activation and Mitochondrial Translocation and to Apoptosis of Human Hepatoma HepG2 Cells* , 2006, Journal of Biological Chemistry.

[27]  T. Willson,et al.  Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. , 2006, Bioorganic & medicinal chemistry letters.

[28]  A. Cederbaum,et al.  Alcohol and oxidative liver injury , 2006, Hepatology.

[29]  F. Roudot-thoraval,et al.  Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C , 2005, Hepatology.

[30]  Michael Karin,et al.  Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.

[31]  I. Rusyn,et al.  Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol‐induced oxidative DNA damage in rodent liver , 2005, Hepatology.

[32]  F. Gonzalez,et al.  Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. , 2005, Mutation research.

[33]  C. Lieber,et al.  Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. , 2004, Alcohol.

[34]  C. Lieber.  CYP2E1: from ASH to NASH. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[35]  Gareth Williams,et al.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.

[36]  M. Maccarrone,et al.  The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis , 2003, Cell Death and Differentiation.

[37]  G. Arteel.  Oxidants and antioxidants in alcohol-induced liver disease. , 2003, Gastroenterology.

[38]  Lei Wang,et al.  Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Waku,et al.  Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[40]  M. Ingelman-Sundberg,et al.  The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. , 2000, Biochemical and biophysical research communications.

[41]  I. Galve-Roperh,et al.  The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase , 2000 .

[42]  I. Galve-Roperh,et al.  The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. , 2000, Molecular pharmacology.

[43]  T. Bonner,et al.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Stallcup,et al.  Hormone-independent Transcriptional Activation and Coactivator Binding by Novel Orphan Nuclear Receptor ERR3* , 1999, The Journal of Biological Chemistry.

[45]  M. Ingelman-Sundberg,et al.  Zonated expression of cytokines in rat liver: Effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole , 1998, Hepatology.

[46]  M. Ingelman-Sundberg,et al.  Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver. , 1994, The Journal of pharmacology and experimental therapeutics.

[47]  P. Beaune,et al.  Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. , 1991, Chemical research in toxicology.